IL37 and dermatitis: The anti-inflammatory characteristics of IL-1Ra, IL-36Ra, IL-37, and IL-38, as well as their constitutive expression in keratinocytes, at the site of skin inflammation suggest that they could represent interesting therapeutic options for inflammatory skin diseases.